Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression?

5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease

(2020) Marcin Banaszczak et al.   Medicina-Lithuania

Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice

(2019) Jiang-Hua Zhou et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis

(2019) Tomoaki Ishihara et al.   INTERNATIONAL IMMUNOLOGY

Diet-Induced Rat Model of Gradual Development of Non-Alcoholic Fatty Liver Disease (NAFLD) with Lipopolysaccharides (LPS) Secretion

(2019) Dominika Maciejewska et al.   Diagnostics

The Eicosanoids, Redox-Regulated Lipid Mediators in Immunometabolic Disorders

(2018) Ana Carolina Araújo et al.   ANTIOXIDANTS & REDOX SIGNALING

The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis

(2018) Yan-Xiao Ji et al.   NATURE MEDICINE

Molecular mechanisms of nonalcoholic fatty liver disease: Potential role for 12-lipoxygenase

(2017) Niharika Samala et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Obesity is positively associated with arachidonic acid-derived 5- and 11-hydroxyeicosatetraenoic acid (HETE)

(2017) Charles Austin Pickens et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Hepatic overproduction of 13-HODE due to ALOX15 upregulation contributes to alcohol-induced liver injury in mice

(2017) Wenliang Zhang et al.   Scientific Reports

Perspectives on Treatment for Nonalcoholic Steatohepatitis

(2016) Guillaume Lassailly et al.   GASTROENTEROLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Resolvin D1 and E1 alleviate the progress of hepatitis toward liver cancer in long-term concanavalin A-induced mice through inhibition of NF-κB activity

(2015) HAOYU KUANG et al.   ONCOLOGY REPORTS

Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis

(2014) Rohit Loomba et al.   JOURNAL OF LIPID RESEARCH

Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis

(2013) Nicola Santoro et al.   Clinical Lipidology

Fatty liver induced by free radicals and lipid peroxidation

(2012) Mayuko Morita et al.   FREE RADICAL RESEARCH

Lipidic last breath of life in patients with alcoholic liver disease

(2012) Joanna Raszeja-Wyszomirska et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

(2010) Ariel E. Feldstein et al.   JOURNAL OF LIPID RESEARCH

Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats

(2009) Zheng-Jie Xu et al.   DIGESTIVE DISEASES AND SCIENCES

Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: a role for resolvins and protectins

(2009) Ana González-Périz et al.   FASEB JOURNAL

The plasma lipidomic signature of nonalcoholic steatohepatitis

(2009) Puneet Puri et al.   HEPATOLOGY

Resolvin E1 Receptor Activation Signals Phosphorylation and Phagocytosis

(2009) Taisuke Ohira et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

12/15-Lipoxygenase Counteracts Inflammation and Tissue Damage in Arthritis

(2009) G. Kronke et al.   JOURNAL OF IMMUNOLOGY